Source: Orthopedic Design & Technology

Isto Biologics: Isto Biologics Acquires Allograft Firm TheraCell

Will introduce TheraFuze DBF (demineralized bone fiber) tech to Isto's Influx line.

Read full article »
Isto Biologics's Competitors | Isto Biologics's News | Isto Biologics's Financials
Stay up-to-date with the latest news on Isto Biologics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Don Brown's photo - CEO of Isto Biologics

CEO

Don Brown

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Isto Biologics